Summary
Machine-generated summaryThe contracting authority in Estonia intends to conclude a framework agreement for the purchase of diagnostic reagents used to detect pathogens with the NAT (nucleic acid testing) method. The framework agreement will run for 4 years. Exclusion grounds and qualification requirements are set out in the tender basis documents, and detailed descriptions are provided in annexes 1 and 2. Economic operators interested in participating must consult the tender basis documents, which govern who may bid and the applicable procedure.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile13 open tenders right now
- Laboratory reagents - Detection of tuberculosis pathogen using NAT method 7 days left
- Biomedical equipment - Purchase of an automated workstation with accessories for pipetting NGS libraries 10 days left
- Dental consumables - Purchase of dental materials and medical supplies 2026-2028 21 days left
Recent awards
- Eesti - Meditsiinilised tarbekaubad - Radioloogias kasutatavad tarvikud
- Eesti - Meditsiiniseadmete remondi- ja hooldusteenused - Olympus endoskoopide pesurite ja kuivatuskappide ennetav hooldus ning remont
- Laboratory reagents - Diagnostics and interpretation software for HLA typing by real-time PCR and NGS methods
Similar tenders
2
days left
€662,675
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,252,456
- Buyer track record on Aperlena
- 191 notices tracked · 97 awarded
- €2,779,407 in awarded contracts
Never miss a tender like this
17 new notices in Medical equipment & pharmaceuticals in Estonia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert